Raymond J Belanger

Title: Innovations by Raymond J Belanger

Introduction

Raymond J Belanger is a notable inventor based in Rensselaer, NY (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative coating processes for tablets. With a total of 2 patents, his work has the potential to enhance the efficacy and user experience of common medications.

Latest Patents

Belanger's latest patents include an aqueous spray-coating process and a method for preparing an easily-swallowed, powder-free, gastric-disintegrable aspirin tablet. The aqueous spray-coating process utilizes an acrylate enteric polymer and plasticizer in water, allowing for commercial-scale application without the need for antiadherents. This innovative method involves controlling the inlet air's dew point and temperature to ensure optimal coating conditions. His second patent focuses on creating a thinly-coated aspirin tablet that minimizes the characteristic taste and discomfort associated with uncoated aspirin. This method employs hydroxypropyl methylcellulose to achieve a coating that allows for rapid disintegration in the stomach.

Career Highlights

Belanger has worked with Sterling Drug Inc., where he has been able to apply his expertise in pharmaceutical innovations. His contributions have not only advanced the field but have also improved the overall experience for consumers taking aspirin and similar medications.

Collaborations

Throughout his career, Belanger has collaborated with notable colleagues such as Phillip M John and Myron Paikoff. These partnerships have likely contributed to the successful development and implementation of his innovative ideas.

Conclusion

Raymond J Belanger's work exemplifies the impact of innovation in the pharmaceutical industry. His patents reflect a commitment to improving medication delivery and user experience. Through his career at Sterling Drug Inc. and collaborations with esteemed colleagues, he continues to influence the field positively.